Advance Care Planning in Primary Care: a Cluster Randomized Clinical Trial (PDA_CAT)

April 26, 2021 updated by: Cristina Lasmarias, University of Vic - Central University of Catalonia

Measuring the Effectiveness of a Training Program for the Implementation of Advance Care Planning in Primary Care Teams: a Cluster Randomized Clinical Trial

The study on the effectiveness of a training program in Advance Care Planning (ACP) with primary care professionals has been designed as a cluster-randomized clinical trial.

Aim: To measure the effectiveness of a training program on ACP in Primary healthcare professionals in a population area of Catalonia. Design: Cluster Randomized clinical trial with a measure of pre-post effectiveness between groups of intervention based on the measurement of self-efficacy in advance care planning. Scope: Barcelona Nord and Maresme (BNM). Population: Primary care doctors and nurses. Sample: doctors and nurses from the Primary Care Service (SAP) of the BNM. The study is divided into 3 phases: 1) Planning: training design, randomization and parallel assignment in 2 arms, online training versus online and face-to-face training; 2) Implementation: data collection pre-intervention and training; 3) Evaluation: post data collection (1 follow-up 4 months after recruitment/ after training) and data analysis. Intervention: both arms (A and B) will carry out the online training which consists of a 10 hours course. Arm B will also do the 6-hour face-to-face workshop, divided into two sessions of 3 hours. Primary outcome: ACP Self-efficacy (using a validated scale Advance Care Planning-Self Efficacy Spanish (ACP_SEs). Secondary outcomes: Socio-demographic: age, gender, years of professional experience and in the professional field, previous knowledge in ACP, previous training in ACP; training Satisfaction; ACP Registration Variables in the medical records of patients identified as chronic advanced patients:% clinical records with ACP processes registration, identification of the surrogate decision-maker, values, preferences, and specific decisions records, identification of the place of care and of death preferred, adequacy of the place of death in case of death. Analysis: calculation of the sample applying correction values for the cluster effect; mean, median, range, confidence interval, and standard deviation of quantitative variables and absolute and relative frequency of qualitative variables. Pre- and post-comparison for the measurement of variance (ANOVA) resulting between the intervention groups from the chi-square test; multivariate logistic regression model and 5% significance level

Study Overview

Status

Completed

Conditions

Study Type

Interventional

Enrollment (Actual)

10

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • Barcelona
      • Arenys de Mar, Barcelona, Spain, 08031
        • Eap Arenys de Mar
      • Mataró, Barcelona, Spain, 08031
        • Eap Gatassa - Mataró 6
      • Mataró, Barcelona, Spain, 08031
        • Eap La Riera - Mataró-1
      • Mataró, Barcelona, Spain, 08031
        • Eap Rocafonda-El Palau - Mataró 3
      • Mataró, Barcelona, Spain, 08031
        • Eap Ronda Cerdanya - Mataró 5
      • Mataró, Barcelona, Spain
        • Eap Ronda Prim - Mataró 7
      • Premià de Mar, Barcelona, Spain, 08031
        • Eap Premià de Mar
      • Sant andreu de llavaneres, Barcelona, Spain, 08031
        • Eap Sant Andreu de Llavaneres
      • Vilassar De Mar, Barcelona, Spain, 08031
        • EAP Vilassar de Mar
      • Vilassar de Dalt, Barcelona, Spain, 08031
        • Eap Vilassar de Dalt

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • Cluster inclusion criteria:

    • Being a primary care team belonging to SAP BNM.

  • Individuals inclusion criteria:

    • Being a doctor or a nurse working at the primary care teams recruited.
    • 280 will take part in the study, belonging to the 10 primary care teams recruited.

Exclusion Criteria:

  • Cluster inclusion criteria:

    • Being teams that share Primary Care Center, in order to avoid contamination between clusters as long as they share patient assignment.

  • Individuals inclusion criteria:

    • Professionals who refuse to be part of the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Health Services Research
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Online traininig group. A
This arm included 5 primary care teams, that carried out a 10 hours online course.
Measurement of the effectiveness of a training program based on the skills and knowledge learning on advance care planning. A 10 hours online course was administered to both arms through an online platform; the 6 hours face-to-face course was administered to each primary care team (5) included in this arm. The 6 hours course was split into 2 sessions of 3 hours each.
Other Names:
  • Self-efficacy improvement on Advance Care Planning
Experimental: online and face-to-face training group. B
This arm included 5 primary care teams, that carried out a 10 hours online course plus a 6h hours face-to-face course
Measurement of the effectiveness of a training program based on the skills and knowledge learning on advance care planning. A 10 hours online course was administered to both arms through an online platform; the 6 hours face-to-face course was administered to each primary care team (5) included in this arm. The 6 hours course was split into 2 sessions of 3 hours each.
Other Names:
  • Self-efficacy improvement on Advance Care Planning

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Advance care planning self-efficacy (ACP-SEs)
Time Frame: 4 months
Self-efficacy on Advance care planing was measured through a recently validated scale into spanish. This scale includes 19 items and it is a 5-point likert scale (1 not at all capable/ 5 completely capable). Due to self-efficacy is a subjective item, no worse o better score is considered. Measurements were collected before training and immediately after training
4 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Clinical records on Advance care planning
Time Frame: 5 months
The clinical records of advanced chronic patients were measured in order to evaluate how ACP were registered before and after the intervention
5 months
Satisfaction with the training process
Time Frame: 1 month
Satisfaction was measured after training on both arms. An ad-hoc 6 point likert ad questionaire was created, including 20 items: satisfaction with contents, organization, teacher, among others...
1 month
Knowledge acquired
Time Frame: 4 months
An ad-hoc 12 items test was created. This outcome was measure before and after training . Correct answers were compared
4 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

September 1, 2019

Primary Completion (Actual)

January 10, 2020

Study Completion (Actual)

April 1, 2020

Study Registration Dates

First Submitted

April 19, 2021

First Submitted That Met QC Criteria

April 26, 2021

First Posted (Actual)

April 30, 2021

Study Record Updates

Last Update Posted (Actual)

April 30, 2021

Last Update Submitted That Met QC Criteria

April 26, 2021

Last Verified

April 1, 2021

More Information

Terms related to this study

Other Study ID Numbers

  • PDA001

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Self Efficacy

Clinical Trials on Impact of a training program

Subscribe